Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.35 (
matrix metalloproteinase 9
)
2,207
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Innate glial response is critical for the induction of inflammatory mediators and recruitment of leukocytes to sites of the injury in the CNS. We have examined the involvement of type I IFN signaling in the mouse hippocampus following sterile injury (transection of entorhinal afferents). Type I IFNs signal through a receptor (IFNAR), which involves activation of IFN regulatory factor (IRF)9, leading to the induction of IFN-stimulated genes including
IRF7
, that in turn enhances the induction of type I IFN. Axonal transection induced upregulation of
IRF7
and IRF9 in hippocampus. Induction of
IRF7
and IRF9 mRNAs was IFNAR dependent. Double-labeling immunofluorescence showed that
IRF7
selectively was induced in Mac-1/CD11b(+) macrophages/microglia in hippocampus after axonal transection.
IRF7
mRNA was also detected in microglia sorted by flow cytometry. Lack of type I IFN signaling resulted in increased leukocyte infiltration into the lesion-reactive hippocampus. Axonal lesion-induced CXCL10 gene expression was abrogated, whereas
matrix metalloproteinase 9
mRNA was elevated in IFNAR-deficient mice. Our findings point to a role for type I IFN signaling in regulation of CNS response to sterile injury.
...
PMID:Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. 2056 59